hydroxycarbamide

The drug is used to treat patients with chronic myeloid leukemia (in chronic or progressive stage), as well as for the treatment of essential thrombocythemia or polycythemia with a high risk of thromboembolic complications.

Form: capsules

ATC: L01XX05

Manufacturer: Medac Gesellschaft für klinische Spezialpräparate mbH (manufacturer responsible for secondary packaging, primary packaging labeling, batch testing/quality control and batch release)

The drug is used for the treatment of chronic myeloid leukemia (both in the early stages before starting specialized therapy and for palliative care), as well as for the treatment of cervical cancer in combination with radiotherapy.

Form: capsules

ATC: L01XX05

Manufacturer: Deva Holding A.S.